https://www.avient.com/sites/default/files/2025-01/AVNT Dec 2022 Earnings Presentation Updated.pdf
W H AT W E D O : M AT E R I A L S C I E N C E
4
CUSTOM
FORMULATION
SUSTA INAB ILITY F OR A BETTER TOMOR ROW
Revenue From Sustainable Solutions* 2016-2021
$310
205
140
80
75
45
40
20
$915M2021 Sales
($ in millions)
*Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”)
**2020 is Pro Forma to include full year of the Clariant Color business
Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12%
5
Key Updates
• Provided progress on 2030 Sustainability Goals
• Emphasized commitment to U.N.
O P S )
21
Sales Adjusted EBITDA
$818
$823
2021 2022
+ 1%
Adjusted EPS
+ 8% - 3%
(in millions) (in millions)
(+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX)
Q3 EBITDA BRIDGE
( P R O F O R M A T O TA L C O M PA N Y )
22
Price increases more than
offset raw material and
supply chain impacts
$ millions
CAI:
68Price / Mix
(44)Inflation
SEM:
41Price / Mix
(26)Inflation
39Net Price Benefit
(14)Wage and Energy Inflation
6Clariant Color Integration Synergies
14Incentives, Other Employee Costs
(11)FX
$137 Q3 2022
Adjusted
EBITDA
$ 142Q3 2021
(39)Demand
Q3 2022 SEGMENT PERFORMANCE
23
CAI
$587
$566
Sales
($ in millions)
$93 $93
EBITDA
SEM Pro Forma
$326 $319
Sales
$70
$62
EBITDA
(+ 4% excluding FX)
- 4% - 2%
(+ 5% excluding FX)
Flat
(+ 7% excluding FX)
- 11%
(- 7% excluding FX)
$500
$585
Cont.
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$585M$3,635M
(1)
Transportation
9%
Healthcare
8%
29
C O L O R , A D D I T I V E S & I N K S
2 0 2 2 R E V E N U E | $ 2 . 3 B I L L I O N
US & Canada
35%
EMEA
40%
Asia
20%
Latin America
5%
END MARKET REGION
30
Packaging
33%
Consumer
22%
Healthcare
9%
Industrial
15%
Transportation
8%
Building &
Construction
11%
Telecommunications
1% Energy
1%
Figures represent 2022 full year estimates
S P E C I A L T Y E N G I N E E R E D M A T E R I A L S
2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N
END MARKET
US & Canada
50%
EMEA
35%
Asia
15%
REGION
31 Figures represent 2022 full year estimates
Packaging
5%
Consumer
19%
Healthcare
8%Industrial
16%
Transportation
10%
Telecommunications
10%
Energy
9%
Defense
15%
Building &
Construction
8%
Packaging
31%
Consumer
28%
Healthcare
8%
Industrial
13%
Building &
Construction
5%
Telecommunications
3%
Energy
2% Defense
1%
Asia
(20% of sales)
Transportation
9%
2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S
B Y E N D M A R K E T
Packaging
29%
Consumer
13%
Healthcare
5%
Industrial
17%
Building &
Construction
11%
Energy
5%
Defense
7%
EMEA
(35% of sales)
Transportation
10%
Packaging
14%
Consumer
23%
Healthcare
11%
Industrial
15%
Building &
Construction
12%
Energy
5%
Defense
7%
US &
Canada
(40% of sales)
Transportation
7%
Packaging
49%
Consumer
22%
Healthcare
8%
Industrial
9%
Building &
Construction
6%
Telecommunications
1%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
3%
Telecommunications
6%
Figures represent 2022 full year estimates32
https://www.avient.com/sites/default/files/2020-08/colormatrix-amosorb-low-haze-product-bulletin-8.5x11.pdf
https://www.avient.com/sites/default/files/2021-11/polyone-belgium-name-change-notarial-certificate-nov-8-2021.pdf
https://www.avient.com/sites/default/files/2021-11/polyone-sarl-egm-deed-name-change-nov-8-2021.pdf
https://www.avient.com/sites/default/files/2024-08/Avient-2023-Sustainability-Report_6.pdf
Winona, Minnesota Pune, India(a) (d)
8.
Taoyuan, Taiwan 8.
Performance—The Highest Ethical Standards; Ethics Hotline; Enterprise Risk Management Pages 68, 69, 70
Avient 2023 Annual Report—Form 10-K Pages 8–15
Operational Safety, Emergency Preparedness & Response
Process Safety Incidents Count (PSIC), Process Safety Total Incident
Rate (PSTIR), and Process Safety Incident Severity Rate (PSISR)
RT-CH-540a.1
1.
https://www.avient.com/sites/default/files/2023-03/AvientRY 2021 CDP Verification Opinion Declaration_07-26-22r%5B96%5D.pdf
Level of Assurance and Qualifications:
Limited
This verification used a materiality threshold of ±5% for aggregate errors in sampled data for each of the
above indicators
GHG Verification Methodology:
Evidence-gathering procedures included, but were not limited to:
Interviews with relevant personnel of Avient and their consultant;
Review of documentary evidence produced by Avient;
Review of Avient data and information systems and methodology for collection, aggregation, analysis and
review of information used to determine GHG emissions; and
Audit of sample of data used by Avient to determine GHG emissions.
https://www.avient.com/sites/default/files/2023-07/Avient_RY 2022 CDP Verification Opinion Declaration_07-24-23%5B30%5D.pdf
Level of Assurance and Qualifications:
Limited
This verification used a materiality threshold of ±5% for aggregate errors in sampled data for each of the
above indicators
GHG Verification Methodology:
Evidence-gathering procedures included, but were not limited to:
Interviews with relevant personnel of Avient and their consultant;
Review of documentary evidence produced by Avient;
Review of Avient data and information systems and methodology for collection, aggregation, analysis and
review of information used to determine GHG emissions; and
Audit of sample of data used by Avient to determine GHG emissions.
https://www.avient.com/sites/default/files/2020-09/oncap-hc-product-bulletin.pdf
KEY CHARACTERISTICS
• Formulated specifically for healthcare product
applications
• Wide portfolio of polymer additive solutions,
including:
- Antimicrobial technology
- Surface energy modification, including
low retention
- Authentication technology
- Lasermarking
- Sterilization and content protection
- Processing optimization
- FDA compliant resin and color changeover
solutions
• OnCap HC Plus certified for USP Class VI and ISO
10993 bio-compatibility requirements; includes
anti-oxidant, lasermarking, antimicrobial,
radiopacifier, anti-stat, and polymer and
gamma stabilization performance additives
OnCap™ HC & OnCap™ HC Plus
Additives for Healthcare
PRODUCT BULLETIN
INDUSTRY SUPPORT
• Supported with a broad range of technical support
and services:
- Restricted medical-grade raw material
selection process
- Sampling program
- World-class FDA cGMP manufacturing facilities
- Batch traceability and formulation
lockdown systems
- FDA Drug Master Files or Medical Device
Files maintenance
MARKETS AND APPLICATIONS
OnCap HC and OnCap HC Plus Additives are an
excellent choice for medical devices and parts,
pharmaceutical or cosmetic packaging, and many other
healthcare related polymer applications.
https://www.avient.com/sites/default/files/2021-04/avient-sustain-2019-210419-interactive.pdf
Hickory, North Carolina
8.
Gyor, Hungary 8.
Santa Clara, Mexico 8.
https://www.avient.com/sites/default/files/2020-10/2019-avient-sustainability-report.pdf
Hickory, North Carolina
8.
Gyor, Hungary 8.
Santa Clara, Mexico 8.